You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development of a miniaturized single-port automated insulin delivery system utilizing a glucose sensing catheter, ultra-concentrated insulin, and an optimized control algorithm
SBC: Pacific Diabetes Technologies Topic: 200ABSTRACT Significance: There are over 5 million people with insulin-treated diabetes in the United States who represent a disproportionately large share of the $237B in direct medical costs attributable to diabetes. The use of continuous glucose monitoring (CGM) has been shown to reduce HbA1c levels, a proven predictor of health outcomes within this population, with the greatest improvement achiev ...
SBIR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health -
Personal relevance of psychotherapy for Asian Americans: A mHealth problem-solving intervention to reduce stress (PRoP-AA)
SBC: IRIS MEDIA INC Topic: 104AbstractThe proposed intervention, Personal relevance of psychotherapy for Asian Americans: A mHealth problem- solving intervention to reduce stress, is designed 1) to increase the use of mental health services by a population that uses them at one third the rate of Whites,1 and 2) to develop a personally-relevant approach to stress-reduction. Practical and cultural barriers inhibit the use of men ...
SBIR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Simultaneous Diagnosis of Dengue and Prognosis of Severe Dengue with a Single Point-of-Care Test
SBC: MABDX INC. Topic: NIAIDDengue is the most common mosquito-borne viral disease and the cause of tremendous morbidity, mortality and economic burden. Yearly, there are an estimated 390 million (M) Dengue virus (DENV) infections, 96M symptomatic cases of Dengue Fever, and 0.5M cases of Severe Dengue. Untreated Severe Dengue has a fatality rate of 20-40%, but the fatality rate drops to less than 1% with timely in-hospital c ...
SBIR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Developing a Technology-based Staff Training Tool for an Empirically-Supported Positive Preventive Intervention For Supporting Children At-Risk for the Development of Disruptive Behavior Disorders
SBC: OREGON RESEARCH BEHAVIORAL INTERVENTION STRATEGIES, INC. Topic: NIMHDProject Summary Disparities in mental health service utilization are more pronounced for children from diverse backgrounds with disproportionately fewer Black and Latino children benefitting from mental health supports and services. Schools are key to addressing these racial and ethnic disparities in mental health service utilization given they are an important point of access and offer children a ...
SBIR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Technology-based Training Tool for an Empirically-Supported Group-Based HIV and STI Prevention Intervention for Juvenile Offenders
SBC: OREGON RESEARCH BEHAVIORAL INTERVENTION STRATEGIES, INC. Topic: 102Project Summary Youth under age 18 involved in the criminal justice system are disproportionately minorities and affected by substance abuse, mental illness, and HIV/STI. Most young offenders are released on community supervision without the STI, mental health, or substance use screening, diagnosis, and treatment afforded detained youth, despite similar rates of risk behavior. Their long-term traj ...
SBIR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health -
A Randomized Phase I Clinical Trial of HydroVax-YFV, a Novel Inativated Yellow Fever Vaccine
SBC: NAJIT TECHNOLOGIES INC Topic: NIAIDAbstract Yellow fever virus (YFV) is a mosquito-borne emerging/re-emerging hemorrhagic fever virus that causes 20- 60% mortality and is endemic in rt40 countries. The current live attenuated YFV vaccine was developed in 1936 and has proven to be effective at saving millions of lives from this devastating disease. Nevertheless, this is a live-attenuated vaccine that is contraindicated in healthy pe ...
SBIR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health -
Novel Nano-immunotherapy for Treatment of Non-small Cell Lung Cancer
SBC: PDX PHARMACEUTICALS, INC. Topic: 102Treatment of non-small cell lung cancer (NSCLC) typically, which requires a combination of many highly toxic drugs and radiation therapy, is not curative. Immune checkpoint inhibitors (ICIs) targeting PD-L1/PD-1 are causing a paradigm shift in NSCLC treatment, yet the 5-year survival rate remains below 20%. This Fast-Track SBIR application aims to develop a novel nano-immunotherapy (termed ARAC - ...
SBIR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
In Situ Tumor Vaccination with a Nano-oligo Therapeutic to Induce Whole-body Antitumor Immune Response
SBC: PDX PHARMACEUTICALS, INC. Topic: 102Significance/Goal. Although immune checkpoint inhibitors (ICIs) have shown impressive outcomes in melanoma patients, the majority of patients fail to respond, mainly due to the absence of tumor-infiltrating T cells. In order to boost the anti-tumor T cell repertoire, we have developed a novel immuno-nanotherapeutic, called “Augmenting Immune Response and Inhibiting Suppressive Environment of tum ...
SBIR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health -
Perovskite-Graphene Energy Integrating Detector for X-Ray Imaging
SBC: KAIROS SENSORS LLC Topic: NIBIBApproximately 12% of women have a false-positive result after one mammogram, and 60% have a false positive after ten yearly mammograms - resulting in the need for secondary screenings. The cost of unnecessary secondary screenings, often due to the inability to differentiate between healthy and unhealthy tissue with the desired accuracy, has been calculated to be $4 billion per year. Increasing the ...
SBIR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Portable hand-held proprietary xenon inhaler for rapid reduction of opioid withdrawal symptoms
SBC: NOBILIS THERAPEUTICS, INC. Topic: NIDASummary/Abstract People with opioid use disorder (OUD) experience aversive opioid withdrawal symptoms (OWS) including nausea, diarrhea, vomiting, and anxiety, which emerge when blood opioid levels wane. These symptoms perpetuate unprescribed opioid use and accompanying morbidity and mortality, costing society nearly $80 billion per year. Withdrawal symptoms also emerge upon initiation of OUD pharm ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health